Cargando…

Anti‐SARS‐CoV‐2 Inhibitory Profile of New Quinoline Compounds in Cell Culture‐Based Infection Models

The presently ongoing pandemic of human SARS‐CoV‐2 infections (COVID‐19) presents an enormous challenge in surveillance, vaccine and antiviral drug development. Here we report the synthesis of new bioactive quinoline‐morpholine hybrid compounds and their virological evaluation, which proves pronounc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herrmann, Lars, Hahn, Friedrich, Wangen, Christina, Marschall, Manfred, Tsogoeva, Svetlana B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015527/ https://www.ncbi.nlm.nih.gov/pubmed/34859926 http://dx.doi.org/10.1002/chem.202103861

Ejemplares similares

The Trimeric Artesunate Analog TF27, a Broadly Acting Anti-Infective Model Drug, Exerts Pronounced Anti-SARS-CoV-2 Activity Spanning Variants and Host Cell Types
por: Hahn, Friedrich, et al.
Publicado: (2022)

(Iso)Quinoline–Artemisinin Hybrids Prepared through Click Chemistry: Highly Potent Agents against Viruses
por: Çapcı, Aysun, et al.
Publicado: (2020)

Development of a PROTAC-Based Targeting Strategy Provides a Mechanistically Unique Mode of Anti-Cytomegalovirus Activity
por: Hahn, Friedrich, et al.
Publicado: (2021)

The Artemisinin-Derived Autofluorescent Compound BG95 Exerts Strong Anticytomegaloviral Activity Based on a Mitochondrial Targeting Mechanism
por: Wild, Markus, et al.
Publicado: (2020)

Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2
por: Hahn, Friedrich, et al.
Publicado: (2021)

Combinatorial Drug Treatments Reveal Promising Anticytomegaloviral Profiles for Clinically Relevant Pharmaceutical Kinase Inhibitors (PKIs)
por: Wild, Markus, et al.
Publicado: (2021)

Assessment of Covalently Binding Warhead Compounds in the Validation of the Cytomegalovirus Nuclear Egress Complex as an Antiviral Target
por: Tillmanns, Julia, et al.
Publicado: (2023)

IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro
por: Hahn, Friedrich, et al.
Publicado: (2020)

Studies of Potency and Efficacy of an Optimized Artemisinin-Quinoline Hybrid against Multiple Stages of the Plasmodium Life Cycle
por: Quadros, Helenita C., et al.
Publicado: (2021)

Cyclin-Dependent Kinases (CDKs) and the Human Cytomegalovirus-Encoded CDK Ortholog pUL97 Represent Highly Attractive Targets for Synergistic Drug Combinations
por: Wild, Markus, et al.
Publicado: (2022)

Synthesis and in vitro Study of Artemisinin/Synthetic Peroxide‐Based Hybrid Compounds against SARS‐CoV‐2 and Cancer
por: Herrmann, Lars, et al.
Publicado: (2022)

New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine †
por: Gentile, Davide, et al.
Publicado: (2020)

Back Cover: Deeper Insight into the Six‐Step Domino Reaction of Aldehydes with Malononitrile and Evaluation of Antiviral and Antimalarial Activities of the Obtained Bicyclic Products (ChemistryOpen 3/2017)
por: Bock, Christina M., et al.
Publicado: (2017)

Deeper Insight into the Six‐Step Domino Reaction of Aldehydes with Malononitrile and Evaluation of Antiviral and Antimalarial Activities of the Obtained Bicyclic Products
por: Bock, Christina M., et al.
Publicado: (2017)

Mass Spectrometry-Based Characterization of the Virion Proteome, Phosphoproteome, and Associated Kinase Activity of Human Cytomegalovirus
por: Couté, Yohann, et al.
Publicado: (2020)

Cytotoxic profiling of artesunic and betulinic acids and their synthetic hybrid compound on neurons and gliomas
por: Ackermann, Annemarie, et al.
Publicado: (2017)

Artemisinin–(Iso)quinoline Hybrids by C−H Activation and Click Chemistry: Combating Multidrug‐Resistant Malaria
por: Çapcı, Aysun, et al.
Publicado: (2019)

Properties of Oligomeric Interaction of the Cytomegalovirus Core Nuclear Egress Complex (NEC) and Its Sensitivity to an NEC Inhibitory Small Molecule
por: Kicuntod, Jintawee, et al.
Publicado: (2021)

Quinoline-Based Hybrid Compounds with Antimalarial Activity
por: Nqoro, Xhamla, et al.
Publicado: (2017)

In-silico studies of inhibitory compounds against protease enzymes of SARS-CoV-2
por: Khan, Saba, et al.
Publicado: (2023)

In Search of Herbal Anti-SARS-Cov2 Compounds
por: Matveeva, Tatiana, et al.
Publicado: (2020)

Computational evidence for nitro derivatives of quinoline and quinoline N-oxide as low-cost alternative for the treatment of SARS-CoV-2 infection
por: Assis, Letícia C., et al.
Publicado: (2021)

Synthesis of Novel Hybrids of Quinazoline and Artemisinin with High Activities against Plasmodium falciparum, Human Cytomegalovirus, and Leukemia Cells
por: Fröhlich, Tony, et al.
Publicado: (2017)

Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants
por: GOC, ANNA, et al.
Publicado: (2022)

Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study
por: Singh, Rajveer, et al.
Publicado: (2020)

Computational Study on the Inhibitory Effect of Natural Compounds against the SARS-CoV-2 Proteins
por: Jayaraj, John Marshal, et al.
Publicado: (2022)

Repurposing Quinoline and Artemisinin Antimalarials as Therapeutics for SARS-CoV-2: Rationale and Implications
por: Firestone, Tessa M., et al.
Publicado: (2021)

Natural tannins as anti-SARS-CoV-2 compounds
por: Wang, Shao-Chun, et al.
Publicado: (2022)

Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease
por: Hemmati, Seyed Ali, et al.
Publicado: (2022)

Retracted: Computational Study on the Inhibitory Effect of Natural Compounds against the SARS-CoV-2 Proteins
por: and Applications, Bioinorganic Chemistry
Publicado: (2023)

Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds
por: Gruber, Lisa, et al.
Publicado: (2018)

Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus
por: Cui, Qinghua, et al.
Publicado: (2018)

Synthesis and antimicrobial activity of novel quinazolinone–thiazolidine–quinoline compounds
por: Desai, N.C., et al.
Publicado: (2013)

New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2
por: Seliem, Israa A., et al.
Publicado: (2021)

The Oligomeric Assemblies of Cytomegalovirus Core Nuclear Egress Proteins Are Associated with Host Kinases and Show Sensitivity to Antiviral Kinase Inhibitors
por: Kicuntod, Jintawee, et al.
Publicado: (2022)

Ultrasound-Assisted Synthesis of Piperidinyl-Quinoline Acylhydrazones as New Anti-Alzheimer’s Agents: Assessment of Cholinesterase Inhibitory Profile, Molecular Docking Analysis, and Drug-like Properties
por: Munir, Rubina, et al.
Publicado: (2023)

Disclosure of Ground‐State Zimmerman‐Möbius Aromaticity in the Radical Anion of [6]Helicene and Evidence for 4π Periodic Aromatic Ring Currents in a Molecular “Metallic” Möbius Strip
por: Mauksch, Michael, et al.
Publicado: (2021)

The Development of Novel Compounds Against Malaria: Quinolines, Triazolpyridines, Pyrazolopyridines and Pyrazolopyrimidines
por: C. S. Pinheiro, Luiz, et al.
Publicado: (2019)

Recent spectrophotometric and electroanalytical methods used for the determination of quinoline-based compounds
por: Alessa, Hussain
Publicado: (2023)

In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease
por: Yañez, Osvaldo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_42p3esg2mj58hca7gev992berr